FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1519621168> ?p ?o ?g. }

• W1519621168 abstract "Preclinical research on animal models of rheumatoid arthritis (RA) is very important for alerting the healthcare and scientific community and pharmaceutical companies of the existence of new or “forgotten” molecules. Most antirheumatics have side-effects when used in higher doses and/or within long-term dosage. Combinatory therapy is expected to have a higher efficacy without increased toxicity. Methotrexate (MTX) has become the main immunosuppressive substance used in the treatment of patients with RA. However, the use of MTX has to be limited due to its toxic manifestations, e.g. abdominal disorder, alopecia, oral ulcers, and cytopenia (Alarcon et al., 1989). Ineffectiveness of treatment can be also observed. In the survey of McKendry and Dale (McKendry & Dale, 1993), due to the risk of treatment, termination was substantiated in 75% of patients with RA taking MTX for 60 months. An adverse drug effect proved to be a more common reason for treatment termination (53%) compared to loss/lack of beneficial effect (22%), other reasons (16%), or lost of follow-up (9%). On the other hand, the therapeutic efficacy of MTX can be increased by combination with other synthetic drugs or inhibitors of TNF-┙ (Smolen et al., 2010). Application of biological therapy (antibodies or soluble receptors of TNF-┙, IL-1 and IL-6) represents a great progress in the therapy of RA. Yet biological treatment is also frequently combined with MTX (Maini et al., 1998; Weinblatt et al., 1999). There are countless possibilities for combinations with MTX. Many substances were neglected when they failed to show good efficacy in monotherapy compared to standard antirheumatics. They would not get a second chance if the expected reduction of clinical parameters (mainly edema of joints) did not materialize, despite the fact that they improved many biochemical disease markers. Our research in the last years was focused on evaluation of new therapeutics for the combinations of the classical immunosuppressive treatment with immunomodulators and compounds affecting reduction/oxidation homeostasis. Development of drugs for the therapy of RA has been very intensive in recent years. Biological therapy targeted on neutralizing the effect of antiinflammatory cytokines, particularly TNF-┙, IL-1 and IL-6, by using antibodies or soluble receptors provided a great progress in RA therapy. However, not even these expensive drugs are able to cure RA" @default.
• W1519621168 created "2016-06-24" @default.
• W1519621168 creator A5014345828 @default.
• W1519621168 creator A5050846282 @default.
• W1519621168 creator A5066306496 @default.
• W1519621168 creator A5068413199 @default.
• W1519621168 creator A5081005362 @default.
• W1519621168 date "2012-01-18" @default.
• W1519621168 modified "2023-09-30" @default.
• W1519621168 title "Modern Pharmacological Approaches to Therapies: Substances Tested in Animal Models of Rheumatoid Arthritis" @default.
• W1519621168 cites W101259488 @default.
• W1519621168 cites W1032292782 @default.
• W1519621168 cites W1247883099 @default.
• W1519621168 cites W1262158971 @default.
• W1519621168 cites W1508726918 @default.
• W1519621168 cites W151794463 @default.
• W1519621168 cites W1567614586 @default.
• W1519621168 cites W1578375703 @default.
• W1519621168 cites W1584738578 @default.
• W1519621168 cites W1591128376 @default.
• W1519621168 cites W1866639487 @default.
• W1519621168 cites W1888977774 @default.
• W1519621168 cites W1952634910 @default.
• W1519621168 cites W1963492252 @default.
• W1519621168 cites W1964613505 @default.
• W1519621168 cites W1970796396 @default.
• W1519621168 cites W1971246867 @default.
• W1519621168 cites W1971710039 @default.
• W1519621168 cites W1974365269 @default.
• W1519621168 cites W1975375148 @default.
• W1519621168 cites W1976765131 @default.
• W1519621168 cites W1976838006 @default.
• W1519621168 cites W1976872447 @default.
• W1519621168 cites W1976987509 @default.
• W1519621168 cites W1977402193 @default.
• W1519621168 cites W1980943812 @default.
• W1519621168 cites W1985322186 @default.
• W1519621168 cites W1988486592 @default.
• W1519621168 cites W1990761779 @default.
• W1519621168 cites W1991164200 @default.
• W1519621168 cites W1996472975 @default.
• W1519621168 cites W1996479055 @default.
• W1519621168 cites W1998292223 @default.
• W1519621168 cites W2000731411 @default.
• W1519621168 cites W2003928089 @default.
• W1519621168 cites W2004449535 @default.
• W1519621168 cites W2009655655 @default.
• W1519621168 cites W2010771259 @default.
• W1519621168 cites W2010929640 @default.
• W1519621168 cites W2011815515 @default.
• W1519621168 cites W2014418201 @default.
• W1519621168 cites W2014856474 @default.
• W1519621168 cites W2016402397 @default.
• W1519621168 cites W2019448678 @default.
• W1519621168 cites W2020538411 @default.
• W1519621168 cites W2031223223 @default.
• W1519621168 cites W2035054007 @default.
• W1519621168 cites W2037465679 @default.
• W1519621168 cites W2038337511 @default.
• W1519621168 cites W2039403566 @default.
• W1519621168 cites W2044313939 @default.
• W1519621168 cites W2047606314 @default.
• W1519621168 cites W2047789654 @default.
• W1519621168 cites W2048528224 @default.
• W1519621168 cites W2052201806 @default.
• W1519621168 cites W2052562838 @default.
• W1519621168 cites W2054888624 @default.
• W1519621168 cites W2057028002 @default.
• W1519621168 cites W2058590788 @default.
• W1519621168 cites W2059643569 @default.
• W1519621168 cites W2061550736 @default.
• W1519621168 cites W2062285406 @default.
• W1519621168 cites W2063731558 @default.
• W1519621168 cites W2065700407 @default.
• W1519621168 cites W2067068975 @default.
• W1519621168 cites W2067396407 @default.
• W1519621168 cites W2067472993 @default.
• W1519621168 cites W2070468924 @default.
• W1519621168 cites W2074528845 @default.
• W1519621168 cites W2075922566 @default.
• W1519621168 cites W2075978331 @default.
• W1519621168 cites W2076470857 @default.
• W1519621168 cites W2076526863 @default.
• W1519621168 cites W2078412897 @default.
• W1519621168 cites W2080107183 @default.
• W1519621168 cites W2080265410 @default.
• W1519621168 cites W2091215793 @default.
• W1519621168 cites W2091526560 @default.
• W1519621168 cites W2094139702 @default.
• W1519621168 cites W2095797798 @default.
• W1519621168 cites W2098866603 @default.
• W1519621168 cites W2100344542 @default.
• W1519621168 cites W2108355568 @default.
• W1519621168 cites W2111773358 @default.
• W1519621168 cites W2113311606 @default.
• W1519621168 cites W2117462751 @default.
• W1519621168 cites W2118447282 @default.
• W1519621168 cites W2122917464 @default.
• W1519621168 cites W2123238252 @default.
• W1519621168 cites W2123370037 @default.

• next